Zeria Pharmaceutical: 1st quarter financial results for the March 2025 period (consolidated) based on Japanese standards.
Zeria Pharmaceutical: Extraordinary Report
Zeria Pharmaceutical: Confirmation letter
Zeria Pharmaceutical: Securities Report - 70th period (April 1, 2023 - March 31, 2024)
Zeria Pharmaceutical: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Zeria Pharmaceutical: Quarterly Report - 70th quarter 3rd quarter (2023/10/01 to 2023/12/31)
Zeria Pharmaceutical: Confirmation letter
Zeria Pharmaceutical: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Zeria Pharmaceutical: Confirmation letter
Zeria Pharmaceutical: Quarterly Report - 70th Second Quarter (2023/07/01 - 2023/09/30)
Zeria Pharmaceutical: Summary of Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Zeria Pharmaceutical: Confirmation letter
Zeria Pharmaceutical: Quarterly Report - First Quarter 70 (2023/04/01 - 2023/06/30)
Zeria Pharmaceutical: Summary of Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Zeria Pharmaceutical: Extraordinary Report
Zeria Pharmaceutical: Confirmation letter
Zeria Pharmaceutical: Securities Report - 69th Period (2022/04/01 - 2023/03/31)
Zeria Pharmaceutical: Notice Concerning Dividends (Dividends Increase) from Surplus Funds
Zeria Pharmaceutical: Summary of Financial Results for the Fiscal Year Ending March 31, 2023 [Japanese GAAP] (Consolidated)
Zeria Pharmaceutical: Confirmation letter
No Data